Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Consultant Clinical Oncologist
Dr Gaurav Kumar received primary medical education and core oncology training from India. After working as a consultant in oncology in India for many years he attained the Certificate of Equivalence for Specialist Registration (CESR) from the General Medical Council (GMC) in 2015. Since then he has been working as Consultant Clinical Oncologist at The James Cook University Hospital, Middlesbrough. Dr Kumar also has peripheral clinics at North Tees and Hartlepool Hospitals NHS Foundation Trust.
With a special interest in lung and urological cancers including prostate and bladder cancer, he has vast experience in treating these conditions with radiotherapy, chemotherapy and immunotherapy. Besides this he has interests in targeted therapies like Stereotactic Ablative Radiotherapy (SABR/SBRT). With a key interest in clinical trials he has been a part of many national and international trials in both thoracic and urological malignancies. He has been involved in many national and international peer reviewed research article publications from time to time.
This consultant has received training from the Rutherford Cancer Centres in the delivery of proton beam therapy. The programme, Proton Therapy Clinical Education, in conjunction with The Perelman School of Medicine at the University of Pennsylvania and IBA, the leading proton beam therapy solutions manufacturer, involves oncologists gaining practical experience in Penn’s Roberts Proton Therapy Center – one of the world’s leading centres of proton therapy research and expertise.
General Medical Council – 7504905
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or
© Copyright Rutherford Health Plc 2017 - 2022
All rights Reserved